Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
11/06/2013 | EP2660241A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
11/06/2013 | EP2659902A1 Leuprolide injection |
11/06/2013 | CN103384527A Ppar活化剂 Ppar activator |
11/06/2013 | CN103382174A Cyclopropyl amine derivatives as histamin h3 receptor modulators |
11/06/2013 | CN103381150A Pharmaceutical composition and application thereof |
11/06/2013 | CN103110933B Elcatonin composition and preparation method thereof |
11/06/2013 | CN102764262B Application of oleanolic acid and retinoic acid pharmaceutical composition in medicament for treating insulin resistance and diabetes |
11/06/2013 | CN102525927B Octreotide acetate preparation and preparation method thereof |
11/06/2013 | CN101679523B Novel fully human anti-vap-1 monoclonal antibodies |
11/05/2013 | US8575307 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
11/05/2013 | US8575152 Non-steroidal compounds useful as glucocorticoid receptor modulators |
11/05/2013 | US8575100 Tc and Re labeled radioactive glycosylated octreotide derivatives |
11/05/2013 | US8575089 Composition for preventing or treating inflammation |
11/05/2013 | US8574622 Controlled release delivery system for nasal applications |
11/05/2013 | CA2491994C Modulators of the glucocorticoid receptor |
11/05/2013 | CA2364417C Peroral gene therapy of diabetes and obesity |
10/31/2013 | WO2013162061A1 Bicyclic pyrimidine compound |
10/31/2013 | WO2003023014A9 Human ion channels |
10/30/2013 | EP2655394A1 Novel 19-nor-steroids and their use for treating progesterone-dependent conditions |
10/30/2013 | EP2655367A1 N-substituted azetidine derivatives |
10/30/2013 | CN103380142A Isoxazolidine derivatives |
10/30/2013 | CN103372055A Extraction process of total polyphenol as hypoglycemic active ingredient in cinnamon, total polyphenol composition and application thereof |
10/30/2013 | CN103372020A Application of Chukrasone A in preparation of medicines for promoting insulin secretion |
10/30/2013 | CN102871015B Pollen health care product and preparation method of pollen health care product |
10/30/2013 | CN101809038B Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
10/30/2013 | CN101786953B Kaurane-type diterpenoid compound as well as preparation method and medical application thereof |
10/29/2013 | US8569543 CCR9 inhibitors and methods of use thereof |
10/29/2013 | US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives |
10/29/2013 | CA2606682C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
10/24/2013 | WO2013157511A1 Arylaminopyrazole derivative |
10/24/2013 | US20130281418 Use of hydroxypregnenolone derivatives for enhancing health and physical performance |
10/24/2013 | US20130281417 Implants and methods for treating inflammation-mediated conditions of the eye |
10/23/2013 | EP2653469A1 Pyrazole derivative |
10/23/2013 | EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
10/23/2013 | EP2651899A2 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof |
10/23/2013 | EP2651251A1 Composition for the treatment of metabolic disorders |
10/23/2013 | CN103356994A Application of CD40 ligand |
10/23/2013 | CN103356660A Application of Chukrasone A in medicines for resisting osteoporosis caused by estrogen deficiency |
10/23/2013 | CN103356617A Application of deacetylase inhibitors in preparation of medicaments for promoting insulin secretion |
10/23/2013 | CN103356602A Application of Chukrasone B in medicines for resisting osteoporosis caused by estrogen deficiency |
10/23/2013 | CN103356593A Application of Chukrasone B in preparation of medicines for promoting insulin secretion |
10/23/2013 | CN103356565A Application of Sarcaboside B in preparation of drug for promoting insulin secretion |
10/23/2013 | CN103356540A Application of Sarcaboside A in medicine for promoting insulin secretion |
10/23/2013 | CN103356476A Method for dissolving flavonoid compounds, carbon glycoside compounds or stilbene compounds and preparation method of injection or injectable powder injection |
10/23/2013 | CN102264362B Phytoestrogenic compositions for preventing or treating symptoms associated with menopause |
10/22/2013 | US8563606 Solid forms of selective androgen receptor modulators |
10/22/2013 | US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation |
10/17/2013 | WO2013154163A1 Novel 5-aryl-1,2-thiazinane derivative |
10/17/2013 | WO2013153129A1 Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors |
10/16/2013 | CN103351415A Method for preparing salidrosides with a series of purities from glossy privet fruit |
10/16/2013 | CN103351336A Naphthalenecarboxamide derivative as inhibitors of protein kinase and histone deacetylase and preparation method thereof |
10/16/2013 | CN101935301B Modulators of ATP-binding cassette transporters |
10/16/2013 | CN101829248B Traditional Chinese medicine for treating goiter |
10/16/2013 | CN101744988B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof |
10/15/2013 | US8557967 Anti-interferon-α antibodies |
10/15/2013 | US8557766 3-hydroxyisothiazole 1-oxide derivatives |
10/15/2013 | US8557512 Method of screening activators and/or inhibitors of insulin receptor substrate 2 |
10/15/2013 | CA2745020C Phytoestrogenic compositions for preventing or treating symptoms associated with menopause |
10/15/2013 | CA2373721C Compounds that bind her2 |
10/15/2013 | CA2367856C Analogs of gastric inhibitory peptide and their use for treatment of diabetes |
10/10/2013 | WO2013152170A1 Selective androgen receptor modulators |
10/10/2013 | US20130266553 Albumin Fusion Proteins |
10/09/2013 | EP2647697A1 Method for producing hematopoietic stem cells using pyrazole compound |
10/09/2013 | CN103342755A Lycium barbarum polysaccharide homogeneous fraction IV, and preparation method and application thereof |
10/09/2013 | CN103342700A 11[beta]-hydroxysteroid dehydrogenase type 1 inhibitor |
10/09/2013 | CN103341090A Medicament for treating gynecomastia and preparation method thereof |
10/09/2013 | CN103340879A Medical application of 11-ketoandrostenedione and 11-ketotestosterone |
10/09/2013 | CN102406821B Traditional Chinese medicine for treating simple goiter |
10/08/2013 | US8552054 Anticancer agents, viricides, psychological disorders |
10/08/2013 | US8551944 Methods of treating glucose metabolism disorders |
10/08/2013 | US8551516 Administration of non-oral androgenic steroids to women |
10/08/2013 | CA2531508C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
10/03/2013 | WO2013143322A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection |
10/03/2013 | WO2013143298A1 Fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
10/03/2013 | US20130261097 Pharmaceutical composition and method for treating hypogonadism |
10/02/2013 | EP2642980A2 Pediatric formulation |
10/02/2013 | CN103338759A 芳香化酶活化剂 Aromatase activator |
10/02/2013 | CN103330907A Hypothyroidism treatment traditional Chinese medicine composition |
10/01/2013 | US8546143 Compositions and methods for inhibiting expression of a target gene |
10/01/2013 | US8545833 Treatment of radiation injury using placental stem cells |
10/01/2013 | CA2723545C 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
10/01/2013 | CA2609726C 17.beta.-hsd1 and sts inhibitors |
10/01/2013 | CA2531507C Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
09/26/2013 | WO2013142214A1 Compounds and methods for treating aberrant adrenocartical cell disorders |
09/25/2013 | EP2641891A1 Pkc- activator |
09/25/2013 | CN103327962A Testosterone formulations |
09/25/2013 | CN103319427A Hexahydrobenzisoxazole compounds and application thereof |
09/25/2013 | CN103316420A Hemorrhoid cushion with function of preventing and curing endocrine dyscrasia |
09/25/2013 | CN103316329A Calcitonin polyion micelle composition |
09/25/2013 | CN103316178A Chinese medicinal compound for improving breeding performance of pregnancy sow |
09/25/2013 | CN103316065A Dandelion fluid decoction pieces and preparation method thereof |
09/25/2013 | CN103316025A Application of p-hydroxyl acetophenone glycosidase to medicine for autoimmunity disease and transplant rejection disease |
09/25/2013 | CN103315982A Usage of magnolol as CYP2E1 enzyme inhibitor |
09/25/2013 | CN102600352B Traditional Chinese medicine for treating xerostomia |
09/25/2013 | CN102526592B Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and immune dysfunction |
09/25/2013 | CN101293888B Xanthine derivative, production and use thereof as a medicament |
09/24/2013 | CA2405557C Albumin fusion proteins |
09/19/2013 | WO2013137284A1 Sulfur amino acid-containing composition |
09/19/2013 | WO2013112949A3 Treatment of circadian rhythm disorders |
09/19/2013 | WO2013102929A4 Novel compounds for treatment of diabetes, obesity or related disorders |